One of my top priorities when I represented Illinois' 10th Congressional District was making sure government programs – like 340B – reached the people that needed help most. Amid a global pandemic stretching our health care resources thin; I think helping those in need is a priority everyone can support. This makes the Trump administration's recent executive order on insulin and EpiPens within the 340B Drug Discount Program especially frustrating. Real fixes to 340B could make a bigger difference for vulnerable or uninsured patients if they improved the way Disproportionate Share Hospitals (DSH) use the program instead of narrowly focusing on federally qualified health centers (FQHCs).